43North

Buffalo is not the first city most healthcare founders consider when mapping their seed strategy, and that is exactly the point of 43North. The accelerator has spent more than a decade running an annual competition that puts one million dollars into each of five winners in exchange for five percent, then asks them to spend a year in Western New York being supported, scrutinized, and connected. Healthcare-adjacent companies have appeared in the cohorts repeatedly, and the program’s posture toward digital health is pragmatic rather than thematic. Founders willing to relocate, or at least to maintain a meaningful presence in Buffalo for the program year, get capital at a price that compares favorably to most accelerator economics on either coast.

The investment thesis at 43North is structurally unusual. The program operates as an evergreen accelerator funded in part by New York State and in part by private capital, and it does not claim a vertical mandate. Instead it underwrites founders who are ambitious enough to win a global pitch competition and operationally pragmatic enough to build a real business in a secondary market. Healthcare exposure has come through digital health entrants who saw a clean million-dollar check at a high valuation as worth the relocation cost. The thesis effectively trades geographic concentration for capital efficiency: companies that can build in Buffalo for a year often emerge with materially lower burn than peers raising similar dollars in San Francisco or Boston. The program does not push companies toward any particular thesis; it picks broadly and lets the cohort sort itself out. Founders pitching deep clinical research, regulated medical devices, or hospital-system-only sales motions will find the program less well-equipped than founders pitching software, services, or consumer-leaning digital health.

Because specific portfolio names are not enumerated in the source data, the program’s healthcare track record is best understood through its competition format. Each year five winners are announced publicly, and at least one or two slots in most cohorts have gone to digital health or health IT companies. Founders considering the program should review recent cohort announcements directly to identify the closest analogs to their own business and reach out to those founders for unfiltered references on the program experience.

The check size is fixed: one million dollars for five percent, on standard terms, with the capital deployed as part of acceptance into the program. There is no negotiation on the headline economics, which is part of the appeal for founders who would rather not run a price discovery process at the seed stage. Follow-on capital is available selectively from 43North’s continuation vehicles and from the broader Buffalo ecosystem. The valuation implied by the headline terms is generous relative to typical accelerator economics, and founders treat the program as a clean institutional seed rather than as a Y-Combinator-style demo-day stepping stone.

Decision-making sits with the program’s investment team and an external selection committee that rotates judges across years. The annual competition format means that decisions are batched: founders apply, advance through pitch rounds, and either win or do not, with limited middle ground. Outside the competition the program does not generally make off-cycle investments, so founders should plan their fundraise around the application calendar rather than expecting opportunistic check-writing.

The approach is straightforward: apply when applications open, prepare for a multi-stage pitch process, and demonstrate willingness to spend meaningful time in Buffalo during the program year. References from prior cohort founders carry weight, and founders should expect questions about why Buffalo rather than why 43North. The program respects operators who treat the relocation as an asset rather than a tax.

Founders should know that 43North is a real million-dollar check at a real five-percent price, not a token accelerator stipend. The program’s value beyond capital comes from the Buffalo ecosystem, the regional talent pool, and the structured introductions to East Coast follow-on investors. It is not a substitute for a coastal seed round, and founders who win should still plan an institutional Series A raise on a normal cadence.